Table 1. The methylation indices (%) for the H19-DMR.
Cases 1−43 | Cases 44−138 | Control subjects | |
Pyrosequencing analysis | |||
CG5 | 4–24 | 35−50 | 33−48 |
CG6 | 5–26 | 36−53 | 34−51 |
CG7 | 4–24 | 35−49 | 30−47 |
CG9 | 5–23 | 34−48 | 30−46 |
COBRA | |||
CG5 (Hpy188I) | 3.3−35.1 | 37.8−60.8 | 36.2−58.5 |
CG16 (AflIII) | 4.1−35.0 | 43.0−59.4 | 38.7−60.0 |
The position of examined CpG dinucleotides (CG5–7, CG9, and CG16) is shown in Figure 1A.
COBRA: combined bisulfite restriction analysis.